Continuous intravenous valproate as abortive therapy for pediatric status migrainosus
The Neurologist Mar 09, 2018
Zafar MS, et al. - This study encompassed the elucidation of the use of continuous intravenous valproate as an abortive therapy for pediatric status migrainosus. It was deduced that continuous intravenous valproate was safe, easy to monitor, and therapeutic in the abortive treatment of status migrainosus in pediatric patients.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries